P Garnier

416 total citations
22 papers, 331 citations indexed

About

P Garnier is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, P Garnier has authored 22 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in P Garnier's work include Growth Hormone and Insulin-like Growth Factors (11 papers), Pituitary Gland Disorders and Treatments (9 papers) and Sexual Differentiation and Disorders (3 papers). P Garnier is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (11 papers), Pituitary Gland Disorders and Treatments (9 papers) and Sexual Differentiation and Disorders (3 papers). P Garnier collaborates with scholars based in France and United States. P Garnier's co-authors include Jean‐Louis Chaussain, J C Job, G Milhaud, L Papoz, D. Simon, C. Senan, M Saint-Paul, F Peillon, A. Brandi and J Gautron and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetologia and European Journal of Endocrinology.

In The Last Decade

P Garnier

22 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Garnier France 10 230 82 81 38 32 22 331
Cyril A. L. Abrams United States 7 277 1.2× 102 1.2× 61 0.8× 90 2.4× 28 0.9× 13 416
R Wolter Belgium 11 232 1.0× 125 1.5× 52 0.6× 82 2.2× 24 0.8× 36 398
Jayme Goldman Brazil 10 186 0.8× 47 0.6× 114 1.4× 17 0.4× 76 2.4× 18 377
M. I. Würzburger Czechia 13 238 1.0× 57 0.7× 209 2.6× 40 1.1× 110 3.4× 24 379
Noah Hardy France 9 161 0.7× 83 1.0× 72 0.9× 26 0.7× 29 0.9× 12 453
M. Hernández Spain 8 183 0.8× 118 1.4× 57 0.7× 52 1.4× 64 2.0× 17 395
M.T. Muñoz-Calvo Spain 9 93 0.4× 69 0.8× 60 0.7× 58 1.5× 48 1.5× 21 268
Ágnes Nemeskéri Hungary 12 111 0.5× 67 0.8× 138 1.7× 25 0.7× 17 0.5× 39 397
Maria Alexandra Magiakou Greece 5 413 1.8× 54 0.7× 81 1.0× 23 0.6× 32 1.0× 6 557
Bin Moore Australia 9 157 0.7× 104 1.3× 24 0.3× 96 2.5× 22 0.7× 9 301

Countries citing papers authored by P Garnier

Since Specialization
Citations

This map shows the geographic impact of P Garnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Garnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Garnier more than expected).

Fields of papers citing papers by P Garnier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Garnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Garnier. The network helps show where P Garnier may publish in the future.

Co-authorship network of co-authors of P Garnier

This figure shows the co-authorship network connecting the top 25 collaborators of P Garnier. A scholar is included among the top collaborators of P Garnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Garnier. P Garnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farnier, Michel, et al.. (2006). Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: the ECHOS (Etude du Cholesterol HDL en Observationnel) French Survey. International Journal of Clinical Practice. 60(10). 1166–1171. 4 indexed citations
2.
Touitou, Yvan, et al.. (1990). Growth hormone (GH) and GH-releasing hormone response to ACTH 1?17 at different times of day. Evidence of a circadian stage dependence. European Journal of Clinical Pharmacology. 38(2). 149–52. 2 indexed citations
3.
Eschwège, É., Annick Fontbonne, D. Simon, et al.. (1990). Oral contraceptives, insulin resistance and ischemic vascular disease. International Journal of Gynecology & Obstetrics. 31(3). 263–269. 11 indexed citations
4.
Peillon, F, M. Le Dafniet, P Garnier, et al.. (1989). Neurohormones provenant de l'antéhypophyse humaine normale et tumorale. Sécrétion et régulation in vitro.. 37(7). 840–845. 1 indexed citations
5.
Peillon, F, M. Le Dafniet, P Garnier, et al.. (1989). Receptors and Neurohormones in Human Pituitary Adenomas. Hormone Research. 31(1-2). 13–18. 12 indexed citations
6.
Simon, D., C. Senan, P Garnier, M Saint-Paul, & L Papoz. (1989). Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. Diabetologia. 32(12). 864–869. 80 indexed citations
7.
Joubert, Dominique, et al.. (1989). Normal and Growth Hormone (GH)-Secreting Adenomatous Human Pituitaries Release Somatostatin and GH-Releasing Hormone. The Journal of Clinical Endocrinology & Metabolism. 68(3). 572–577. 56 indexed citations
8.
Peillon, F, et al.. (1989). [Neurohormones coming from the normal and tumoral human anterior pituitary. Secretion and regulation in vitro].. PubMed. 37(7). 840–5. 6 indexed citations
9.
Peillon, F, P Garnier, A. Brandi, et al.. (1988). [In vitro secretion of somatostatin (SRIH) by human adenomatous somatotropic cells. Relation with somatotropic hormone (GH) release and modulation by thyroliberin (TRH)].. PubMed. 306(4). 161–6. 7 indexed citations
10.
Job, J C, Jean‐Louis Chaussain, P Garnier, et al.. (1988). [Long-term fate of pituitary dwarfs treated with growth hormone].. PubMed. 45(3). 169–73. 2 indexed citations
11.
Toublanc, J E, et al.. (1988). EFFECT OF LHRH ANALOGUE IN PUBERTAL PATIENTS WITH ISOLATED GROWTH HORMONE DEFICIENCY. Pediatric Research. 23(1). 117–117. 1 indexed citations
12.
Garnier, P, et al.. (1988). [Results of hormonal studies in 23 adolescents with renal failure treated by chronic dialysis].. PubMed. 36(8). 988–94. 1 indexed citations
13.
Job, Jean‐Claude, et al.. (1987). Dose‐response Relationship in the Treatment of Hypopituitary Children with Human Growth Hormone: a Retrospective Survey. Acta Paediatrica. 76(s337). 93–105. 13 indexed citations
14.
Garnier, P, et al.. (1986). Effect of the Variations of Female Sex Hormones during the Menstrual Cycle upon Serum Somatomedin and Growth-Promoting Activity. Hormone Research. 23(1). 31–37. 12 indexed citations
15.
Dafniet, M. Le, P Garnier, A. Brandi, et al.. (1985). Interaction between Somatostatin and TRH on Growth Hormone Secretion in Perifused Human Growth Hormone Tumor Cells. Hormone Research. 21(4). 235–239. 3 indexed citations
16.
Dafniet, M. Le, P Garnier, D. Bression, et al.. (1985). Correlative Studies between the Presence of Thyrotropin-Releasing Hormone (TRH) Receptors and the In Vitro Stimulation of Growth-Hormone (GH) Secretion in Human GH-Secreting Adenomas. Hormone and Metabolic Research. 17(9). 476–479. 10 indexed citations
17.
Garnier, P, et al.. (1981). [Association of hyperlipidemia, acute pancreatitis and diabetic keto-acidosis. A case report (author's transl)].. PubMed. 56(47-68). 2035–7. 2 indexed citations
18.
Peillon, F, F. Cesselin, P Garnier, et al.. (1977). Secrétion et synthèse de la prolactine par les adénomes somatotropes humains en culture organotypique. Effet de la somatostatine (SRIF).. Annales d Endocrinologie. 38(2). 1 indexed citations
19.
Chaussain, Jean‐Louis, et al.. (1974). Effect of Synthetic Luteinizing Hormone-Releasing Hormone (LH-RH) on the Release of Gonadotropins in Hypophyso-Gonadal Disorders of Children and Adolescents. III. Hypopituitarism. The Journal of Clinical Endocrinology & Metabolism. 38(1). 58–63. 26 indexed citations
20.
Job, J C, P Garnier, Jean‐Louis Chaussain, & G Milhaud. (1972). ELEVATION OF SERUM GONADOTROPINS (LH AND FSH) AFTER RELEASING HORMONE (LH-RH) INJECTION IN NORMAL CHILDREN AND IN PATIENTS WITH DISORDERS OF PUBERTY1. The Journal of Clinical Endocrinology & Metabolism. 35(3). 473–476. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cyril A. L. Abrams Breakdown of academic impact, for papers by R Wolter Breakdown of academic impact, for papers by Jayme Goldman Breakdown of academic impact, for papers by M. I. Würzburger Breakdown of academic impact, for papers by Noah Hardy Breakdown of academic impact, for papers by M. Hernández Breakdown of academic impact, for papers by M.T. Muñoz-Calvo Breakdown of academic impact, for papers by Ágnes Nemeskéri Breakdown of academic impact, for papers by Maria Alexandra Magiakou Breakdown of academic impact, for papers by Bin Moore
Rankless by CCL
2026